Phototherapy for Dementia

MG
DL
Overseen ByDonna Lawson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this research is to determine whether the use of phototherapy can help reduce behavioral and psychological symptoms, including agitation in people with dementia.

Who Is on the Research Team?

SP

Stephanie P. Chambers, APRN, CNS

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

Inclusion Criteria

Adult patients admitted on the inpatient Domitilla 3D or 4D unit
Documented diagnosis of dementia or suspected major neurocognitive disorder
I have agreed to join the study or have someone who can consent for me.
See 1 more

Exclusion Criteria

Pregnancy
Bipolar disorder
I have macular degeneration, blindness, or sensitivity to light.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants in the phototherapy arm will receive bright light therapy for 60 minutes, 3 times per day for 5 days

1 week

Follow-up

Participants are monitored for safety and effectiveness after treatment

1-2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Phototherapy

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: PhototherapyExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+